Single CpG site methylation controls estrogen receptor gene transcription and correlates with hormone therapy resistance
Single CpG site methylation controls estrogen receptor gene transcription and correlates with hormone therapy resistance
复制标题
DOI:
10.1016/j.jsbmb.2017.04.001
复制
发表时间:
2017-07-01
影响因子:
4.1
通讯作者:
Hayashi, Shin-ichi
中科院分区:
文献类型:
--
作者:
Tsuboi, Kouki;Nagatomo, Takamasa;Hayashi, Shin-ichi
Hormone therapy is the most effective treatment for patients with estrogen receptor alpha-positive breast cancers. However, although resistance occurs during treatment in some cases and often reflects changed estrogen receptor alpha status, the relationship between changes in estrogen receptor a expression and resistance to therapy are poorly understood. In this study, we identified a mechanism for altered estrogen receptor alpha expression during disease progression and acquired hormone therapy resistance in aromatase inhibitor-resistant breast cancer cell lines. Subsequently, we investigated promoter switching and DNA methylation status of the estrogen receptor alpha promoter, and found marked changes of methylation at a single CpG site (CpG4) in resistant cells. In addition, luciferase reporter assays showed reduced transcriptional activity from this methylated CpG site. This CpG region was also completely conserved among species, suggesting that it acts as a methylation-sensitive Ets-2 transcription factor binding site, as confirmed using chromatin immunoprecipitation assays. In estrogen receptor alpha-positive tumors, CpG4 methylation levels were inversely correlated with estrogen receptor alpha expression status, suggesting that single CpG site plays an important role in the regulation of estrogen receptor alpha transcription.